Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.

@article{Brilakis2013EffectOT,
  title={Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.},
  author={Emmanouil S Brilakis and Claes Held and Bernhard Meier and Frank Johan Cools and Marc J Claeys and Jan Hein Cornel and Philip A Aylward and Basil S. Lewis and Douglas Weaver and Gunnar Brandrup-Wognsen and Susanna R. Stevens and Anders Himmelmann and Lars Wallentin and Stefan Karl James},
  journal={American heart journal},
  year={2013},
  volume={166 3},
  pages={474-80}
}
BACKGROUND Patients with prior coronary artery bypass graft surgery (CABG) who present with an acute coronary syndrome have a high risk for recurrent events. Whether intensive antiplatelet therapy with ticagrelor might be beneficial compared with clopidogrel is unknown. In this substudy of the PLATO trial, we studied the effects of randomized treatment dependent on history of CABG. METHODS Patients participating in PLATO were classified according to whether they had undergone prior CABG. The… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 24 references

A randomizedcontrolled trial of a paclitaxel-eluting stent vs a similar baremetal stent in saphenous vein graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial

ES Brilakis, C Lichtenwalter, JA de Lemos
J Am Coll Cardiol 2009;53:919-28 • 2009

Similar Papers

Loading similar papers…